论文部分内容阅读
维兰特罗三苯乙酸盐(vilanterol trifenatate,1),化学名为(R)-4-[2-[[6-[2-[(2,6-二氯苄基)氧基]-乙氧基]己基]氨基]-1-羟基乙基]-2-羟甲基苯酚三苯乙酸盐,是葛兰素史克(GSK)公司开发的新型长效β_2受体激动剂。1与糠酸氟替卡松的复方制剂(商品名Breo Ellipta)、与芜地溴铵的复方制剂(商品名Anoro Ellipta)分别于2013年5月和
Vilanterol trifenatate (1) with the chemical name (R) -4- [2- [[6- [2 - [(2,6- dichlorobenzyl) oxy] Ethoxy] hexyl] amino] -1-hydroxyethyl] -2-hydroxymethylphenol triphenylacetate, is a new long-acting beta-2 receptor agonist developed by GSK. 1 and fluticasone furoate (Breo Ellipta), and a combination preparation of urtodinium bromide (trade name Anoro Ellipta) in May 2013 and